Individualised Follow-Up for Patients after Haematopoietic Stem Cell Transplantation (HSCT) and Treatment for Relapse of Cancer

Introduction: Patients treated with HSCT or for relapse of cancer are at high risk to develop late effects. In order to optimise follow-up in these patients and prevent unnecessary examinations, individualised follow-up recommendations are necessary. Methods: Using follow-up recommendations of the GPOH treatment protocols, of European and American haematological societies and published data on treatment related late effects, individualised, risk based, exposure-related follow-up recommendations are to be generated. These recommendations will be based on the underlying disease, disease specific risks, treatment g…